nodes	percent_of_prediction	percent_of_DWPC	metapath
Terlipressin—AVPR1A—respiratory system—obesity	0.0152	0.25	CbGeAlD
Terlipressin—Abdominal cramps—Phentermine—obesity	0.0136	0.0521	CcSEcCtD
Terlipressin—AVPR2—respiratory system—obesity	0.0126	0.207	CbGeAlD
Terlipressin—AVPR1A—adrenal gland—obesity	0.0092	0.152	CbGeAlD
Terlipressin—AVPR2—adipose tissue—obesity	0.0085	0.14	CbGeAlD
Terlipressin—AVPR1A—endocrine gland—obesity	0.00798	0.132	CbGeAlD
Terlipressin—AVPR1A—liver—obesity	0.00719	0.119	CbGeAlD
Terlipressin—Cardiac failure—Phentermine—obesity	0.00685	0.0261	CcSEcCtD
Terlipressin—Pregnancy—Bupropion—obesity	0.00626	0.0239	CcSEcCtD
Terlipressin—Torsade de pointes—Sibutramine—obesity	0.00581	0.0222	CcSEcCtD
Terlipressin—Ventricular fibrillation—Sibutramine—obesity	0.00532	0.0203	CcSEcCtD
Terlipressin—Acute coronary syndrome—Phentermine—obesity	0.00508	0.0194	CcSEcCtD
Terlipressin—Myocardial infarction—Phentermine—obesity	0.00505	0.0193	CcSEcCtD
Terlipressin—Ventricular extrasystoles—Sibutramine—obesity	0.00451	0.0172	CcSEcCtD
Terlipressin—Tachycardia—Methamphetamine—obesity	0.00446	0.017	CcSEcCtD
Terlipressin—Tachycardia—Benzphetamine—obesity	0.0043	0.0164	CcSEcCtD
Terlipressin—Pallor—Bupropion—obesity	0.00428	0.0163	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Methamphetamine—obesity	0.00395	0.0151	CcSEcCtD
Terlipressin—Tachycardia—Phendimetrazine—obesity	0.00392	0.015	CcSEcCtD
Terlipressin—Bradycardia—Cimetidine—obesity	0.0039	0.0149	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Benzphetamine—obesity	0.00381	0.0145	CcSEcCtD
Terlipressin—Hypertension—Phentermine—obesity	0.00348	0.0133	CcSEcCtD
Terlipressin—Chest pain—Phentermine—obesity	0.00343	0.0131	CcSEcCtD
Terlipressin—Tachycardia—Phenylpropanolamine—obesity	0.00335	0.0128	CcSEcCtD
Terlipressin—Menopausal symptoms—Orlistat—obesity	0.00324	0.0124	CcSEcCtD
Terlipressin—Tachycardia—Phentermine—obesity	0.00321	0.0122	CcSEcCtD
Terlipressin—Abdominal pain—Phendimetrazine—obesity	0.00318	0.0121	CcSEcCtD
Terlipressin—Diarrhoea—Methamphetamine—obesity	0.00313	0.0119	CcSEcCtD
Terlipressin—Atrial fibrillation—Sibutramine—obesity	0.00312	0.0119	CcSEcCtD
Terlipressin—Dyspnoea—Phenylpropanolamine—obesity	0.00306	0.0117	CcSEcCtD
Terlipressin—Diarrhoea—Benzphetamine—obesity	0.00302	0.0115	CcSEcCtD
Terlipressin—Chest pain—Diethylpropion—obesity	0.00298	0.0114	CcSEcCtD
Terlipressin—Headache—Methamphetamine—obesity	0.00287	0.0109	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Phentermine—obesity	0.00284	0.0108	CcSEcCtD
Terlipressin—Tachycardia—Diethylpropion—obesity	0.00279	0.0106	CcSEcCtD
Terlipressin—Headache—Benzphetamine—obesity	0.00276	0.0105	CcSEcCtD
Terlipressin—Hot flush—Bupropion—obesity	0.00276	0.0105	CcSEcCtD
Terlipressin—Diarrhoea—Phendimetrazine—obesity	0.00275	0.0105	CcSEcCtD
Terlipressin—Menopausal symptoms—Bupropion—obesity	0.00273	0.0104	CcSEcCtD
Terlipressin—Pallor—Topiramate—obesity	0.00273	0.0104	CcSEcCtD
Terlipressin—Tachycardia—Cimetidine—obesity	0.00265	0.0101	CcSEcCtD
Terlipressin—Nausea—Benzphetamine—obesity	0.00262	0.01	CcSEcCtD
Terlipressin—Abdominal pain—Phentermine—obesity	0.0026	0.00991	CcSEcCtD
Terlipressin—Dyspnoea—Diethylpropion—obesity	0.00255	0.00973	CcSEcCtD
Terlipressin—Headache—Phendimetrazine—obesity	0.00252	0.00961	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Diethylpropion—obesity	0.00247	0.00942	CcSEcCtD
Terlipressin—Nausea—Phendimetrazine—obesity	0.00239	0.00911	CcSEcCtD
Terlipressin—Diarrhoea—Phentermine—obesity	0.00225	0.00858	CcSEcCtD
Terlipressin—Acute coronary syndrome—Sibutramine—obesity	0.00225	0.00857	CcSEcCtD
Terlipressin—Myocardial infarction—Sibutramine—obesity	0.00223	0.00853	CcSEcCtD
Terlipressin—Vomiting—Phenylpropanolamine—obesity	0.00218	0.00833	CcSEcCtD
Terlipressin—Vomiting—Phentermine—obesity	0.00209	0.00797	CcSEcCtD
Terlipressin—Bradycardia—Sibutramine—obesity	0.00208	0.00795	CcSEcCtD
Terlipressin—Headache—Phentermine—obesity	0.00206	0.00786	CcSEcCtD
Terlipressin—Nausea—Phenylpropanolamine—obesity	0.00204	0.00778	CcSEcCtD
Terlipressin—Acute coronary syndrome—Bupropion—obesity	0.00196	0.00747	CcSEcCtD
Terlipressin—Diarrhoea—Diethylpropion—obesity	0.00196	0.00747	CcSEcCtD
Terlipressin—Nausea—Phentermine—obesity	0.00195	0.00745	CcSEcCtD
Terlipressin—Myocardial infarction—Bupropion—obesity	0.00195	0.00743	CcSEcCtD
Terlipressin—Diarrhoea—Cimetidine—obesity	0.00186	0.0071	CcSEcCtD
Terlipressin—Angiopathy—Sibutramine—obesity	0.00186	0.00708	CcSEcCtD
Terlipressin—Malnutrition—Orlistat—obesity	0.00184	0.00702	CcSEcCtD
Terlipressin—Vomiting—Diethylpropion—obesity	0.00182	0.00694	CcSEcCtD
Terlipressin—Headache—Diethylpropion—obesity	0.00179	0.00684	CcSEcCtD
Terlipressin—Malnutrition—Sibutramine—obesity	0.00178	0.0068	CcSEcCtD
Terlipressin—Hot flush—Topiramate—obesity	0.00176	0.0067	CcSEcCtD
Terlipressin—Menopausal symptoms—Topiramate—obesity	0.00174	0.00664	CcSEcCtD
Terlipressin—Vomiting—Cimetidine—obesity	0.00173	0.0066	CcSEcCtD
Terlipressin—Headache—Cimetidine—obesity	0.0017	0.0065	CcSEcCtD
Terlipressin—Nausea—Diethylpropion—obesity	0.0017	0.00648	CcSEcCtD
Terlipressin—Cardiac disorder—Bupropion—obesity	0.00166	0.00632	CcSEcCtD
Terlipressin—Hyponatraemia—Topiramate—obesity	0.00165	0.00629	CcSEcCtD
Terlipressin—Angiopathy—Bupropion—obesity	0.00162	0.00618	CcSEcCtD
Terlipressin—Nausea—Cimetidine—obesity	0.00162	0.00617	CcSEcCtD
Terlipressin—Chest pain—Orlistat—obesity	0.00157	0.00598	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.00156	0.00594	CcSEcCtD
Terlipressin—Malnutrition—Bupropion—obesity	0.00155	0.00593	CcSEcCtD
Terlipressin—Hypertension—Sibutramine—obesity	0.00154	0.00587	CcSEcCtD
Terlipressin—Chest pain—Sibutramine—obesity	0.00152	0.00579	CcSEcCtD
Terlipressin—Nervous system disorder—Orlistat—obesity	0.00147	0.00562	CcSEcCtD
Terlipressin—Skin disorder—Orlistat—obesity	0.00146	0.00557	CcSEcCtD
Terlipressin—Tachycardia—Sibutramine—obesity	0.00142	0.00541	CcSEcCtD
Terlipressin—Skin disorder—Sibutramine—obesity	0.00141	0.00539	CcSEcCtD
Terlipressin—Hypertension—Bupropion—obesity	0.00134	0.00512	CcSEcCtD
Terlipressin—Chest pain—Bupropion—obesity	0.00132	0.00504	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.00131	0.00501	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Orlistat—obesity	0.0013	0.00495	CcSEcCtD
Terlipressin—Dyspnoea—Sibutramine—obesity	0.0013	0.00495	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Sibutramine—obesity	0.00125	0.00479	CcSEcCtD
Terlipressin—Nervous system disorder—Bupropion—obesity	0.00124	0.00474	CcSEcCtD
Terlipressin—Tachycardia—Bupropion—obesity	0.00124	0.00472	CcSEcCtD
Terlipressin—Skin disorder—Bupropion—obesity	0.00123	0.0047	CcSEcCtD
Terlipressin—Abdominal pain—Orlistat—obesity	0.00119	0.00453	CcSEcCtD
Terlipressin—Bradycardia—Topiramate—obesity	0.00116	0.00441	CcSEcCtD
Terlipressin—Abdominal pain—Sibutramine—obesity	0.00115	0.00438	CcSEcCtD
Terlipressin—Dyspnoea—Bupropion—obesity	0.00113	0.00431	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Bupropion—obesity	0.00109	0.00417	CcSEcCtD
Terlipressin—Cardiac disorder—Topiramate—obesity	0.00105	0.00402	CcSEcCtD
Terlipressin—Angiopathy—Topiramate—obesity	0.00103	0.00393	CcSEcCtD
Terlipressin—Diarrhoea—Orlistat—obesity	0.00103	0.00392	CcSEcCtD
Terlipressin—Abdominal pain—Bupropion—obesity	0.001	0.00382	CcSEcCtD
Terlipressin—Diarrhoea—Sibutramine—obesity	0.000994	0.0038	CcSEcCtD
Terlipressin—Malnutrition—Topiramate—obesity	0.000989	0.00377	CcSEcCtD
Terlipressin—Vomiting—Orlistat—obesity	0.000955	0.00364	CcSEcCtD
Terlipressin—Headache—Orlistat—obesity	0.000941	0.00359	CcSEcCtD
Terlipressin—Vomiting—Sibutramine—obesity	0.000924	0.00353	CcSEcCtD
Terlipressin—Headache—Sibutramine—obesity	0.000911	0.00347	CcSEcCtD
Terlipressin—Nausea—Orlistat—obesity	0.000892	0.0034	CcSEcCtD
Terlipressin—Diarrhoea—Bupropion—obesity	0.000867	0.00331	CcSEcCtD
Terlipressin—Nausea—Sibutramine—obesity	0.000863	0.00329	CcSEcCtD
Terlipressin—Hypertension—Topiramate—obesity	0.000854	0.00326	CcSEcCtD
Terlipressin—Chest pain—Topiramate—obesity	0.000842	0.00321	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000836	0.00319	CcSEcCtD
Terlipressin—Vomiting—Bupropion—obesity	0.000806	0.00307	CcSEcCtD
Terlipressin—Headache—Bupropion—obesity	0.000794	0.00303	CcSEcCtD
Terlipressin—Nervous system disorder—Topiramate—obesity	0.000792	0.00302	CcSEcCtD
Terlipressin—Tachycardia—Topiramate—obesity	0.000788	0.00301	CcSEcCtD
Terlipressin—Skin disorder—Topiramate—obesity	0.000784	0.00299	CcSEcCtD
Terlipressin—Nausea—Bupropion—obesity	0.000753	0.00287	CcSEcCtD
Terlipressin—Dyspnoea—Topiramate—obesity	0.00072	0.00275	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Topiramate—obesity	0.000697	0.00266	CcSEcCtD
Terlipressin—Abdominal pain—Topiramate—obesity	0.000638	0.00244	CcSEcCtD
Terlipressin—Diarrhoea—Topiramate—obesity	0.000552	0.00211	CcSEcCtD
Terlipressin—Vomiting—Topiramate—obesity	0.000513	0.00196	CcSEcCtD
Terlipressin—Headache—Topiramate—obesity	0.000506	0.00193	CcSEcCtD
Terlipressin—Nausea—Topiramate—obesity	0.00048	0.00183	CcSEcCtD
Terlipressin—AVPR1A—GPCR downstream signaling—AGT—obesity	0.000106	0.000156	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—GNB3—obesity	0.000105	0.000155	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—AGT—obesity	0.000105	0.000155	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HTR1B—obesity	0.000105	0.000155	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CRH—obesity	0.000105	0.000155	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HTR1B—obesity	0.000104	0.000154	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CRH—obesity	0.000104	0.000154	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SDC1—obesity	0.000104	0.000153	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—TYK2—obesity	0.000104	0.000153	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PRKCD—obesity	0.000103	0.000153	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—PIK3CB—obesity	0.000103	0.000153	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IGF2—obesity	0.000103	0.000152	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SDC1—obesity	0.000103	0.000152	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—RHOA—obesity	0.000103	0.000152	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PRKCD—obesity	0.000103	0.000152	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—GNAS—obesity	0.000102	0.000151	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—AKR1C3—obesity	0.000102	0.000151	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—PIK3R1—obesity	0.000102	0.00015	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—AKR1C3—obesity	0.000101	0.00015	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—HTR2A—obesity	0.000101	0.00015	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—C3—obesity	0.000101	0.000149	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—HTR2A—obesity	0.000101	0.000148	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—C3—obesity	0.0001	0.000148	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—APOB—obesity	0.0001	0.000148	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NPS—obesity	9.94e-05	0.000147	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NPS—obesity	9.87e-05	0.000146	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CCL5—obesity	9.79e-05	0.000145	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—F2—obesity	9.78e-05	0.000144	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PRKCB—obesity	9.78e-05	0.000144	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—DRD1—obesity	9.75e-05	0.000144	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HTR2C—obesity	9.75e-05	0.000144	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—F2—obesity	9.71e-05	0.000143	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PRKCB—obesity	9.71e-05	0.000143	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—DRD1—obesity	9.68e-05	0.000143	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HTR2C—obesity	9.68e-05	0.000143	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—AGT—obesity	9.61e-05	0.000142	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—LPL—obesity	9.57e-05	0.000141	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—AGT—obesity	9.54e-05	0.000141	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—FOXO1—obesity	9.5e-05	0.00014	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—RPS6KB1—obesity	9.49e-05	0.00014	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NTRK2—obesity	9.49e-05	0.00014	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ADRB1—obesity	9.44e-05	0.000139	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NTRK2—obesity	9.42e-05	0.000139	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—PIK3CB—obesity	9.39e-05	0.000139	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ADRB1—obesity	9.38e-05	0.000138	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3CG—obesity	9.36e-05	0.000138	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3CG—obesity	9.29e-05	0.000137	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PARP1—obesity	9.24e-05	0.000136	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—GHRL—obesity	9.24e-05	0.000136	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PARP1—obesity	9.18e-05	0.000136	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—GHRL—obesity	9.18e-05	0.000136	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—DRD4—obesity	9.17e-05	0.000135	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—DRD4—obesity	9.1e-05	0.000134	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—POMC—obesity	8.91e-05	0.000131	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PRKCB—obesity	8.88e-05	0.000131	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—F2—obesity	8.88e-05	0.000131	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—POMC—obesity	8.84e-05	0.000131	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PRKCD—obesity	8.82e-05	0.00013	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PRKCB—obesity	8.81e-05	0.00013	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—F2—obesity	8.81e-05	0.00013	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CNR1—obesity	8.75e-05	0.000129	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CNR1—obesity	8.69e-05	0.000128	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—HTR2A—obesity	8.63e-05	0.000127	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—C3—obesity	8.62e-05	0.000127	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TCF7L2—obesity	8.6e-05	0.000127	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—AKT2—obesity	8.56e-05	0.000126	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—DRD2—obesity	8.54e-05	0.000126	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TCF7L2—obesity	8.54e-05	0.000126	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—AKT2—obesity	8.5e-05	0.000125	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CG—obesity	8.5e-05	0.000125	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—DRD2—obesity	8.48e-05	0.000125	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—GCG—obesity	8.46e-05	0.000125	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PTPN1—obesity	8.46e-05	0.000125	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CG—obesity	8.44e-05	0.000125	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PTPN1—obesity	8.39e-05	0.000124	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—GCG—obesity	8.39e-05	0.000124	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3CD—obesity	8.23e-05	0.000121	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IRS2—obesity	8.2e-05	0.000121	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—AGT—obesity	8.19e-05	0.000121	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3CD—obesity	8.17e-05	0.000121	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—POMC—obesity	8.09e-05	0.000119	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PRL—obesity	8.07e-05	0.000119	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—POMC—obesity	8.03e-05	0.000119	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—LEP—obesity	8.02e-05	0.000118	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—APOE—obesity	8.02e-05	0.000118	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PRL—obesity	8.01e-05	0.000118	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CAV1—obesity	7.95e-05	0.000117	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—STK11—obesity	7.95e-05	0.000117	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—APOA1—obesity	7.93e-05	0.000117	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CCL2—obesity	7.91e-05	0.000117	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—STK11—obesity	7.89e-05	0.000117	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PLG—obesity	7.86e-05	0.000116	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CCL2—obesity	7.86e-05	0.000116	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—RHOA—obesity	7.85e-05	0.000116	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PLG—obesity	7.8e-05	0.000115	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—RHOA—obesity	7.79e-05	0.000115	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—AKT2—obesity	7.77e-05	0.000115	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3R1—obesity	7.77e-05	0.000115	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—AKT2—obesity	7.72e-05	0.000114	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3R1—obesity	7.71e-05	0.000114	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—FOXO3—obesity	7.67e-05	0.000113	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—ESR1—obesity	7.66e-05	0.000113	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ADRB2—obesity	7.65e-05	0.000113	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—FOXO3—obesity	7.62e-05	0.000112	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ADRB2—obesity	7.6e-05	0.000112	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—F2—obesity	7.57e-05	0.000112	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PRKCB—obesity	7.57e-05	0.000112	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SOCS1—obesity	7.54e-05	0.000111	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SOCS1—obesity	7.48e-05	0.00011	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—BAD—obesity	7.48e-05	0.00011	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CD—obesity	7.47e-05	0.00011	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SOCS3—obesity	7.44e-05	0.00011	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CD—obesity	7.42e-05	0.000109	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SOCS3—obesity	7.39e-05	0.000109	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—GNB3—obesity	7.29e-05	0.000108	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CG—obesity	7.24e-05	0.000107	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—GNB3—obesity	7.24e-05	0.000107	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—TYK2—obesity	7.19e-05	0.000106	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3CB—obesity	7.17e-05	0.000106	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IGF2—obesity	7.16e-05	0.000106	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IRS1—obesity	7.16e-05	0.000106	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—TYK2—obesity	7.13e-05	0.000105	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—RHOA—obesity	7.13e-05	0.000105	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3CB—obesity	7.12e-05	0.000105	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IGF2—obesity	7.11e-05	0.000105	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—GNAS—obesity	7.1e-05	0.000105	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—RHOA—obesity	7.08e-05	0.000104	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3R1—obesity	7.05e-05	0.000104	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—GNAS—obesity	7.04e-05	0.000104	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3R1—obesity	7e-05	0.000103	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—APOB—obesity	6.95e-05	0.000103	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—APOB—obesity	6.9e-05	0.000102	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—POMC—obesity	6.89e-05	0.000102	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—INS—obesity	6.85e-05	0.000101	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CCL5—obesity	6.79e-05	0.0001	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CCL2—obesity	6.74e-05	9.96e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CCL5—obesity	6.74e-05	9.95e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—LPL—obesity	6.63e-05	9.8e-05	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IGF1—obesity	6.63e-05	9.79e-05	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—AKT2—obesity	6.63e-05	9.78e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—FOXO1—obesity	6.59e-05	9.73e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—LPL—obesity	6.59e-05	9.73e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—RPS6KB1—obesity	6.58e-05	9.71e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—FOXO1—obesity	6.54e-05	9.66e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—RPS6KB1—obesity	6.53e-05	9.64e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CB—obesity	6.51e-05	9.61e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CB—obesity	6.46e-05	9.54e-05	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CD—obesity	6.37e-05	9.4e-05	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—PIK3CA—obesity	6.31e-05	9.31e-05	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—SERPINE1—obesity	6.3e-05	9.3e-05	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TYK2—obesity	6.12e-05	9.04e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PRKCD—obesity	6.11e-05	9.03e-05	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—RHOA—obesity	6.07e-05	8.97e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PRKCD—obesity	6.07e-05	8.96e-05	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—NOS3—obesity	6.01e-05	8.87e-05	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3R1—obesity	6.01e-05	8.87e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HTR2A—obesity	5.98e-05	8.83e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—C3—obesity	5.97e-05	8.82e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HTR2A—obesity	5.94e-05	8.77e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—C3—obesity	5.93e-05	8.76e-05	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—PIK3CA—obesity	5.73e-05	8.45e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IRS2—obesity	5.68e-05	8.39e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—AGT—obesity	5.68e-05	8.38e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IRS2—obesity	5.64e-05	8.33e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—AGT—obesity	5.64e-05	8.32e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—LEP—obesity	5.56e-05	8.21e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—APOE—obesity	5.56e-05	8.21e-05	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CB—obesity	5.55e-05	8.19e-05	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MTOR—obesity	5.55e-05	8.19e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—LEP—obesity	5.52e-05	8.15e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—APOE—obesity	5.52e-05	8.15e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CAV1—obesity	5.51e-05	8.14e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—APOA1—obesity	5.5e-05	8.12e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CAV1—obesity	5.47e-05	8.08e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—APOA1—obesity	5.46e-05	8.06e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ESR1—obesity	5.31e-05	7.84e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ESR1—obesity	5.27e-05	7.78e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PRKCB—obesity	5.24e-05	7.74e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—F2—obesity	5.24e-05	7.74e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—F2—obesity	5.21e-05	7.69e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PRKCB—obesity	5.21e-05	7.69e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—BAD—obesity	5.18e-05	7.65e-05	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—AKT1—obesity	5.15e-05	7.6e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—BAD—obesity	5.15e-05	7.6e-05	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—IL6—obesity	5.07e-05	7.49e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CG—obesity	5.02e-05	7.41e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CG—obesity	4.98e-05	7.36e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IRS1—obesity	4.96e-05	7.32e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IRS1—obesity	4.93e-05	7.27e-05	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MMP9—obesity	4.82e-05	7.12e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—POMC—obesity	4.78e-05	7.05e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—INS—obesity	4.75e-05	7.01e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—POMC—obesity	4.74e-05	7e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—INS—obesity	4.72e-05	6.96e-05	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MAPK8—obesity	4.69e-05	6.92e-05	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—AKT1—obesity	4.68e-05	6.91e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CCL2—obesity	4.67e-05	6.9e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CCL2—obesity	4.64e-05	6.85e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IGF1—obesity	4.6e-05	6.78e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—AKT2—obesity	4.59e-05	6.78e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IGF1—obesity	4.56e-05	6.74e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—AKT2—obesity	4.56e-05	6.73e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CD—obesity	4.41e-05	6.51e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CD—obesity	4.38e-05	6.47e-05	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3CA—obesity	4.37e-05	6.45e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SERPINE1—obesity	4.36e-05	6.44e-05	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3CA—obesity	4.34e-05	6.41e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SERPINE1—obesity	4.33e-05	6.4e-05	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—STAT3—obesity	4.29e-05	6.33e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TYK2—obesity	4.24e-05	6.27e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TYK2—obesity	4.21e-05	6.22e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—RHOA—obesity	4.21e-05	6.22e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—RHOA—obesity	4.18e-05	6.17e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3R1—obesity	4.17e-05	6.15e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NOS3—obesity	4.17e-05	6.15e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3R1—obesity	4.14e-05	6.11e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NOS3—obesity	4.14e-05	6.11e-05	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MYC—obesity	3.98e-05	5.88e-05	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TGFB1—obesity	3.97e-05	5.87e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CA—obesity	3.97e-05	5.86e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CA—obesity	3.94e-05	5.82e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MTOR—obesity	3.85e-05	5.68e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CB—obesity	3.85e-05	5.68e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CB—obesity	3.82e-05	5.64e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MTOR—obesity	3.82e-05	5.64e-05	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—AKT1—obesity	3.57e-05	5.27e-05	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—AKT1—obesity	3.54e-05	5.23e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—IL6—obesity	3.51e-05	5.19e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—IL6—obesity	3.49e-05	5.15e-05	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CA—obesity	3.38e-05	4.99e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MMP9—obesity	3.34e-05	4.94e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MMP9—obesity	3.32e-05	4.9e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MAPK8—obesity	3.25e-05	4.8e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—AKT1—obesity	3.24e-05	4.79e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MAPK8—obesity	3.23e-05	4.77e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—AKT1—obesity	3.22e-05	4.75e-05	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IL6—obesity	3e-05	4.42e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—STAT3—obesity	2.97e-05	4.39e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—STAT3—obesity	2.95e-05	4.36e-05	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—AKT1—obesity	2.76e-05	4.08e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MYC—obesity	2.76e-05	4.08e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TGFB1—obesity	2.76e-05	4.07e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MYC—obesity	2.74e-05	4.05e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TGFB1—obesity	2.74e-05	4.04e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CA—obesity	2.34e-05	3.46e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CA—obesity	2.33e-05	3.44e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IL6—obesity	2.08e-05	3.07e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IL6—obesity	2.06e-05	3.04e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—AKT1—obesity	1.92e-05	2.83e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—AKT1—obesity	1.9e-05	2.81e-05	CbGpPWpGaD
